Skip to content

Moringa Oleifera Supplementation for Reducing Heavy Metals Toxicity and Oxidative Stress in Pregnant Women

Moringa Oleifera Supplementation for Reducing Heavy Metals Toxicity and Oxidative Stress in Pregnant Women

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12625000162415
Acronym
MOTHM
Enrollment
40
Registered
2025-02-12
Start date
2024-07-11
Completion date
2025-02-21
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study protocol aims to evaluate the effectiveness of Moringa Oleifera supplementation in reducing heavy metal toxicity and oxidative stress biomarkers, 8-hydroxy-2'-deoxyguanosine (8-OHdG) and malondialdehyde (MDA), in pregnant women exposed to high levels of heavy metals. Methods: A quasi-experimental, non-randomized pre-post test design is used. Pregnant women with elevated heavy metal levels, identified through initial screening, will be included in the intervention group, receiving Moringa Oleifera supplementation for two months. The control group will consist of women from similar geographical regions who will not receive the intervention. Primary outcomes will include changes in heavy metal concentrations, measured using inductively coupled plasma mass spectrometry (ICP-MS). Secondary outcomes will focus on reductions in oxidative stress biomarkers, measured via enzyme-linked immunosorbent assay (ELISA). Statistical analyses, including ANCOVA, will be used to adjust for baseline differences between the groups. our hypothesis is that Supplementation of Moringa Leaves decreases heavy metals, MDA, and 8-OHdg level.

Interventions

The intervention group will receive moringa extract supplement (2000 mg/day) consisting of two capsules twice per day. The duration of the administration will be two months. We collaborate with the health cadres at the health center. We ask them to supervise, remind, and ensure the mother take the capsules. We created a WhatsApp group for cadres to monitor and remind them to supervise the participants.. The cadres will remind the participant to administer the moringa through the whatsapp group

The intervention group will receive moringa extract supplement (2000 mg/day) consisting of two capsules twice per day. The duration of the administration will be two months. We collaborate with the health cadres at the health center. We ask them to supervise, remind, and ensure the mother take the capsules. We created a WhatsApp group for cadres to monitor and remind them to supervise the participants.. The cadres will remind the participant to administer the moringa through the whatsapp group and the participant report it the groups. Mode of administration is powder in capsule.. Researcher determine allocation based on the mother's level of heavy metals. We determine each of the intervention and control group is in the same health centres to ease the monitoring

Sponsors

Directorate of Research, Technology, and Community Service of the Ministry of Education, Culture, Research, and Technology, Indonesia
Lead SponsorGovernment body

Study design

Allocation
Non-randomised trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
15 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

1. Pregnancy during the second or third trimester 2. Intention to deliver in Makassar 3. Not enduring twin pregnancy 4. Absence of chronic diseases 5. Living in Makassar for a period exceeding one year 6. Blood levels of mercury, lead, or cadmium exceed the reference value

Exclusion criteria

1. pregnant with the condition that is impossible to take blood 2. Not available for involvement

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026